BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 17941864)

  • 1. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.
    Walsh JP; Bremner AP; Bulsara MK; O'Leary P; Leedman PJ; Feddema P; Michelangeli V
    Arch Intern Med; 2005 Nov; 165(21):2467-72. PubMed ID: 16314542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
    Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
    Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45).
    Unnikrishnan RI; Rema M; Pradeepa R; Deepa M; Shanthirani CS; Deepa R; Mohan V
    Diabetes Care; 2007 Aug; 30(8):2019-24. PubMed ID: 17488949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
    Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
    Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
    Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years.
    Kvetny J; Heldgaard PE; Bladbjerg EM; Gram J
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):232-8. PubMed ID: 15272919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study.
    Pedro RA; Ramon SA; Marc BB; Juan FB; Isabel MM
    Ophthalmic Epidemiol; 2010 Aug; 17(4):251-65. PubMed ID: 20642348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic cardiovascular disease risk factors and their clustering in subclinical hypothyroidism.
    Ashizawa K; Imaizumi M; Usa T; Tominaga T; Sera N; Hida A; Ejima E; Neriishi K; Soda M; Ichimaru S; Nakashima E; Fujiwara S; Maeda R; Nagataki S; Eguchi K; Akahoshi M
    Clin Endocrinol (Oxf); 2010 May; 72(5):689-95. PubMed ID: 20447067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Cheung N; Wang JJ; Klein R; Couper DJ; Sharrett AR; Wong TY
    Diabetes Care; 2007 Jul; 30(7):1742-6. PubMed ID: 17389333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
    Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study.
    Doney AS; Lee S; Leese GP; Morris AD; Palmer CN
    Circulation; 2005 Jun; 111(22):2927-34. PubMed ID: 15927971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes.
    Mansournia N; Riyahi S; Tofangchiha S; Mansournia MA; Riahi M; Heidari Z; Hazrati E
    J Endocrinol Invest; 2017 Mar; 40(3):289-295. PubMed ID: 27738906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.